Inactive Instrument
Protide Pharmaceuticals, Inc. Stock
Stocks
PPMD
US74371A1034
Biotechnology & Medical Research
OTC Markets Traded| 1 day | +83.33% |
| Manager | Title | Age | Since |
|---|---|---|---|
Milo R. Polovina
CEO | Chief Executive Officer | 70 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Milo R. Polovina
CHM | Chairman | 70 | 2010-02-17 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +83.33% | +46.67% | - | - | 886K | |
| +1.77% | +5.54% | +11.43% | +37.22% | 47.97B | |
| -1.69% | +1.48% | +50.57% | +33.71% | 44.5B | |
| +2.56% | +7.34% | +366.69% | +609.24% | 43.93B | |
| +0.24% | +2.85% | +10.67% | +87.77% | 41.03B | |
| -0.62% | -1.11% | +4.65% | +46.13% | 29.85B | |
| -0.28% | +1.07% | +24.58% | +149.55% | 17.27B | |
| +3.37% | +9.21% | +8.32% | - | 15.34B | |
| +1.55% | +0.64% | +29.21% | +48.11% | 15.3B | |
| -2.21% | -4.70% | - | - | 14.82B | |
| Average | +8.24% | +2.35% | +63.26% | +144.53% | 30B | |
| Weighted average by Cap. | +0.24% | +2.86% | +80.27% | +159.87% |
Employees
3
